Tech Center 1600 • Art Units: 1626
This examiner grants 84% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17913292 | Solid Dispersions of Amorphous 3,4-Diphenyl-4,5-Dihydro-1H-Pyrazole Derivatives, Compositions Comprising them and Uses Thereof as Cannabinoid CB1 Receptor Inhibitors | Non-Final OA | Novo Nordisk A/S |
| 18319920 | AROMATIC BRIDGED RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | Non-Final OA | Hoffmann-La Roche Inc. |
| 18555226 | ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | Non-Final OA | LG CHEM, LTD. |
| 18281125 | QUINOXALINE UREA INHIBITORS OF IKK-BETA AND NF-KB | Non-Final OA | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA |
| 17925765 | HALOGENATED BENZOTHIADIAZINES FOR THE TREATMENT OF CANCER | Non-Final OA | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA |
| 18557827 | PROCESS | Non-Final OA | JOHNSON MATTHEY PUBLIC LIMITED COMPANY |
| 18500142 | METHOD FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS AND METHOD FOR SUPPRESSING PROGRESS OF AMYOTROPHIC LATERAL SCLEROSIS | Non-Final OA | MITSUBISHI TANABE PHARMA CORPORATION |
| 18752081 | BAX ACTIVATORS AND USES THEREOF IN CANCER THERAPY | Non-Final OA | Albert Einstein College of Medicine |
| 18287301 | FLUOROCARBON COMPOSITIONS AND METHODS FOR ENHANCING IMMUNOTHERAPY | Non-Final OA | NuvOx Pharma LLC |
| 18582046 | DEUTERATED COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | Non-Final OA | PMV Pharmaceuticals, Inc. |
| 18567085 | COMBINATION TREATMENT OF CANCER WITH A PARP INHIBITOR AND A LIPOPHILIC STATIN | Non-Final OA | TESARO, INC. |
| 18210215 | BLEND CONTAINING CARBAMATE COMPOUND FOR PREVENTION, MITIGATION, OR TREATMENT OF SCHIZOPHRENIA | Final Rejection | SK BIOPHARMACEUTICALS CO., LTD. |
| 18004935 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PYROXASULFONE, FENOXASULFONE AND VARIOUS SULFONE ANALOGS OF 5,5-DIMETHYL-4H-1,2-OXAZOLE | Non-Final OA | Adama Agan Ltd. |
| 18288743 | NOVEL HETEROCYCLIC COMPOUNDS | Non-Final OA | FLORATEK PHARMA S.A. |
| 18348185 | INDUSTRIAL PROCESS FOR THE PREPARATION OF HEXANOIC ACID, 6-(NITROOXY)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ETHYLAMINO)-7-OXO-2-HEPTEN-1-YL]-3,5-DIHYDROXYCYCLOPENTYL]-1-(2-PHENYLETHYL)-2-PROPEN-1-YL ESTER AND HIGH PURE PRODUCT | Non-Final OA | Nicox SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy